Braftovi 75 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FY9WF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,478
Award facts
- Contract value 100% obligated
- $11,477.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,477.83 delivery order to AmerisourceBergen Drug Corp on April 10, 2026, for BRAFTOVI 75 mg capsule, 90-count units, under firm fixed-price terms with a completion date of May 1, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside. AmerisourceBergen Drug Corp operates as a division of Cencora, Inc. and supplies pharmaceutical products to federal medical procurement through its extensive IDC portfolio with DLA Troop Support Medical.
Quick answers
Who was awarded contract SPE2DR26FY9WF?
SPE2DR26FY9WF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 10, 2026.
How much is contract SPE2DR26FY9WF worth?
The government has obligated $11,478 on SPE2DR26FY9WF.
Is contract SPE2DR26FY9WF an order under another contract?
Yes. SPE2DR26FY9WF is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY9WF competed?
The extent of competition for SPE2DR26FY9WF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award